Journal
Pediatric Neurology
Publication Date
4-1-2024
Volume
153
First Page
11
Last Page
18
Document Type
Open Access Publication
DOI
10.1016/j.pediatrneurol.2024.01.003
Rights and Permissions
Mendell JR, Proud C, Zaidman CM, Mason S, Darton E, Wang S, Wandel C, Murphy AP, Mercuri E, Muntoni F, McDonald CM. Practical Considerations for Delandistrogene Moxeparvovec Gene Therapy in Patients With Duchenne Muscular Dystrophy. Pediatr Neurol. 2024 Apr;153:11-18. doi: 10.1016/j.pediatrneurol.2024.01.003. © 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Mendell, Jerry R; Proud, Crystal; Zaidman, Craig M; Mason, Stefanie; Darton, Eddie; Wang, Shufang; Wandel, Christoph; Murphy, Alexander P; Mercuri, Eugenio; Muntoni, Francesco; and McDonald, Craig M, "Practical considerations for delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy." Pediatric Neurology. 153, 11 - 18. (2024).
https://digitalcommons.wustl.edu/oa_4/4534
Department
ICTS (Institute of Clinical and Translational Sciences)
